Clinical Trials Directory

Trials / Completed

CompletedNCT01009229

A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

A Reduced 11 Beta Hydroxysteroid Dehydrogenase 2 (11 Beta HSD2) Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation according to official guidelines. An assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.

Detailed description

Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation. The assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow and high salt dietsHigh salt diet: 150mmol/d Low salt diet: 30mmol/d

Timeline

Start date
2009-06-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2009-11-06
Last updated
2011-05-25

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01009229. Inclusion in this directory is not an endorsement.